Market Overview:
The global nasal decongestant market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of respiratory diseases, growing awareness about the benefits of nasal decongestants, and rising demand for over-the-counter (OTC) drugs. The global nasal decongestant market is segmented by type into nasal strips, tablets, sprays, and capsules. The spray segment is expected to grow at a CAGR of 6.1% from 2018 to 2030 due to its high efficacy in relieving congestion and other symptoms associated with respiratory diseases. By application, the asthma segment accounted for the largest share of the global nasal decongestant market in 2017 and is projected to grow at a CAGR of 5.8% from 2018to 2030 owing to an increase in asthma cases across the globe.
Product Definition:
A nasal decongestant is a drug that is used to relieve congestion in the nose. It may be a pill, liquid, or spray.
Nasal Strips:
Nasal strips are thin, adhesive plastic films that are placed in the nose to block blood vessels and widen the airway. They work by reducing swelling and congestion in the nasal passages. The product is available as a single-use or multi-use pack containing different sizes of strips for different uses.
Tablet:
Tablet is a compressed block of material, which is used for the production of nasal decongestant. It contains active ingredients such as phenylephrine and caffeine. These are used to reduce congestion caused due to cold or allergies. The other ingredients present in it may consist of local anesthetics, sugar, sweeteners (such as saccharin), and inert substances (such as cornstarch).
Application Insights:
The asthma segment dominated the global market in 2017. The growing prevalence of asthma and its increasing impact on a global level are the major factors driving this segment. According to the Global Asthma Report 2018, published by Global Asthma Network, it is estimated that around 300 million people globally suffer from asthma and approximately 1.3 million deaths are caused by this disease every year.
The use of nasal sprays for treating allergies is also very common these days as they have been proved to be more effective than traditional allergy shots in most cases due to their short-term effects only.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position throughout the forecast period owing to increasing awareness about nasal decongestants and their benefits, high disposable income of consumers, and availability of advanced healthcare facilities. Moreover, presence of key manufacturers in this region will also help it maintain its dominance during the forecast period.
Asia Pacific is anticipated to witness significant growth over the coming years due to rising demand for non-invasive methods for treatment of nasal congestion and related disorders. Increasing number of surgeries required for rhinoplasty procedures are also driving growth in this region as patients prefer less invasive treatments resulting into higher adoption rates for nasal decongestants products such as sprays & tablets which are easy to use & provide fast results compared with other conventional methods such as surgery or allergy shots (allergen immunotherapy).
Growth Factors:
- Increasing prevalence of respiratory diseases: The global prevalence of respiratory diseases is increasing every year. This is leading to an increase in the demand for nasal decongestants, as they are one of the most effective ways to treat these conditions.
- Growing awareness about the benefits of nasal decongestants: There is a growing awareness among people about the benefits of using nasal decongestants, which is driving their demand worldwide.
- Rising number of sinus infections: The number of sinus infections is rising globally due to changing lifestyles and increasing air pollution levels. This is leading to an increase in the demand for nasal decongestants, as they are one of the most effective ways to treat sinus infections.
- Growing popularity of over-the-counter (OTC) drugs: The popularity of OTC drugs is growing rapidly across the world due to their easy availability and affordability. This is boosting the sales growth prospects for nasal decongestant products globally.
Scope Of The Report
Report Attributes
Report Details
Report Title
Nasal Decongestant Market Research Report
By Type
Nasal Strips, Tablet, Spray, Capsule
By Application
Asthma, Cold, Nasal Allergies
By Companies
Abbott Laboratories, Glaxosmithkline, Cipla, Bayer, ADAPT Pharma, Patrick Parsons, Nidda Healthcare, Procter and Gamble, Rugby Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
201
Number of Tables & Figures
141
Customization Available
Yes, the report can be customized as per your need.
Global Nasal Decongestant Market Report Segments:
The global Nasal Decongestant market is segmented on the basis of:
Types
Nasal Strips, Tablet, Spray, Capsule
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Asthma, Cold, Nasal Allergies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Glaxosmithkline
- Cipla
- Bayer
- ADAPT Pharma
- Patrick Parsons
- Nidda Healthcare
- Procter and Gamble
- Rugby Laboratories
Highlights of The Nasal Decongestant Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Nasal Strips
- Tablet
- Spray
- Capsule
- By Application:
- Asthma
- Cold
- Nasal Allergies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nasal Decongestant Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nasal decongestant medications are used to relieve congestion and sneezing. They work by opening up the nasal passages and making it easier for air to flow through.
Some of the major companies in the nasal decongestant market are Abbott Laboratories, Glaxosmithkline, Cipla, Bayer, ADAPT Pharma, Patrick Parsons, Nidda Healthcare, Procter and Gamble, Rugby Laboratories.
The nasal decongestant market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Nasal Decongestant Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Nasal Decongestant Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Nasal Decongestant Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Nasal Decongestant Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Nasal Decongestant Market Size & Forecast, 2018-2028
4.5.1 Nasal Decongestant Market Size and Y-o-Y Growth
4.5.2 Nasal Decongestant Market Absolute $ Opportunity
Chapter 5 Global Nasal Decongestant Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Nasal Decongestant Market Size Forecast by Type
5.2.1 Nasal Strips
5.2.2 Tablet
5.2.3 Spray
5.2.4 Capsule
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Nasal Decongestant Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Nasal Decongestant Market Size Forecast by Applications
6.2.1 Asthma
6.2.2 Cold
6.2.3 Nasal Allergies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Nasal Decongestant Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Nasal Decongestant Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Nasal Decongestant Analysis and Forecast
9.1 Introduction
9.2 North America Nasal Decongestant Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Nasal Decongestant Market Size Forecast by Type
9.6.1 Nasal Strips
9.6.2 Tablet
9.6.3 Spray
9.6.4 Capsule
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Nasal Decongestant Market Size Forecast by Applications
9.10.1 Asthma
9.10.2 Cold
9.10.3 Nasal Allergies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Nasal Decongestant Analysis and Forecast
10.1 Introduction
10.2 Europe Nasal Decongestant Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Nasal Decongestant Market Size Forecast by Type
10.6.1 Nasal Strips
10.6.2 Tablet
10.6.3 Spray
10.6.4 Capsule
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Nasal Decongestant Market Size Forecast by Applications
10.10.1 Asthma
10.10.2 Cold
10.10.3 Nasal Allergies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Nasal Decongestant Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Nasal Decongestant Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Nasal Decongestant Market Size Forecast by Type
11.6.1 Nasal Strips
11.6.2 Tablet
11.6.3 Spray
11.6.4 Capsule
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Nasal Decongestant Market Size Forecast by Applications
11.10.1 Asthma
11.10.2 Cold
11.10.3 Nasal Allergies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Nasal Decongestant Analysis and Forecast
12.1 Introduction
12.2 Latin America Nasal Decongestant Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Nasal Decongestant Market Size Forecast by Type
12.6.1 Nasal Strips
12.6.2 Tablet
12.6.3 Spray
12.6.4 Capsule
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Nasal Decongestant Market Size Forecast by Applications
12.10.1 Asthma
12.10.2 Cold
12.10.3 Nasal Allergies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Nasal Decongestant Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Nasal Decongestant Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Nasal Decongestant Market Size Forecast by Type
13.6.1 Nasal Strips
13.6.2 Tablet
13.6.3 Spray
13.6.4 Capsule
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Nasal Decongestant Market Size Forecast by Applications
13.10.1 Asthma
13.10.2 Cold
13.10.3 Nasal Allergies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Nasal Decongestant Market: Competitive Dashboard
14.2 Global Nasal Decongestant Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Glaxosmithkline
14.3.3 Cipla
14.3.4 Bayer
14.3.5 ADAPT Pharma
14.3.6 Patrick Parsons
14.3.7 Nidda Healthcare
14.3.8 Procter and Gamble
14.3.9 Rugby Laboratories
